GlassScriptPhysician profile
Matthew Robert Denny
NPI 1619351467
$5,527.86
in general payments reported to CMS, 2019-2025
24 companies · $1,517 in 2025
The $1,517 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $173 · 2021: $535 · 2022: $1,050 · 2023: $966 · 2024: $935 · 2025: $1,517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,354 · Entertainment: $63.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,354.25 |
| Entertainment | $63.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,837.34 | 2019-2025 | Hydrus Microstent, Clareon, Centurion |
| Allergan, INC. | $273.91 | 2021-2022 | |
| Oyster Point Pharma, INC. | $272.54 | 2022-2025 | Tyrvaya, Ryzumvi |
| Johnson & Johnson Surgical Vision, INC. | $215.75 | 2021-2025 | Tecnis Iol, Tecnis Iol, Amo Phaco Needle |
| Abbvie INC. | $207.01 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $204.48 | 2023-2025 | Cequa |
| Bausch & Lomb Americas INC. | $195.51 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $180.77 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $145.02 | 2021-2025 | |
| Sight Sciences, INC. | $141.04 | 2021-2024 | Tearcare System |
| Johnson & Johnson Vision Care, INC. | $130.83 | 2022-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $114.13 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $96.38 | 2019-2021 | |
| Thea Pharma INC. | $91.30 | 2024-2025 | Iyuzeh |
| Rxsight INC | $88.82 | 2023-2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $65.52 | 2024-2025 | Vevye |
| Optos, INC. | $63.30 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Dompe US, INC. | $47.42 | 2021-2024 | Oxervate |
| Novartis Pharmaceuticals Corporation | $39.34 | 2021-2022 | |
| Rayner Intraocular Lenses Limited | $34.96 | 2025 | Omidria |
| Glaukos Corporation | $28.87 | 2020 | |
| New World Medical,INC. | $19.95 | 2022 | |
| Lundbeck LLC | $18.70 | 2019 | |
| Eyevance Pharmaceuticals LLC | $14.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Denny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.